Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor.

Saved in:
Bibliographic Details
Title: Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor.
Authors: Gang Zhao, Martin Voorbach, H. Doug Falls, Brian Droz, Sevan Brodjian, Yau Yi Lau, Rajesh R. Iyengar, Ju Gao, Andrew S. Judd, Seble H. Wagaw, Matthew M. Ravn, Kenneth M. Engstrom, John K. Lynch, Mathew M. Mulhern, Jennifer Freeman, Brian D. Dayton, Xiaojun Wang, Nelson Grihalde, Dennis Fry, David W. A. Beno
Source: Journal of Medicinal Chemistry. Jan2008, Vol. 51 Issue 3, p380-383. 4p.
Database: Academic Search Ultimate
Description
ISSN:00222623
DOI:10.1021/jm7013887